We are live on ! Find out more
AUGX

Augmedix, Inc. Common Stock

Delisted

AUGX was delisted on the 1st of October, 2024.

22 hedge funds and large institutions have $64.9M invested in Augmedix, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

7% less capital invested

Capital invested by funds: $69.5M → $64.9M (-$4.59M)

15% less funds holding

Funds holding: 2622 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.35%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
3
Increased
7
Reduced
6
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VF
26
Virtu Financial
New York
-$70K -22,235 Closed
Envestnet Asset Management
27
Envestnet Asset Management
Illinois
-$33K -10,483 Closed
TCM
28
TD Capital Management
Tennessee
-$5K -1,505 Closed
US Bancorp
29
US Bancorp
Minnesota
-$4K -1,374 Closed

AUGX Hedge Fund Activity: Q1 2022 in Review

22 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q1 2022, worth a combined $64.9M — down 6.6% from $69.5M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of AUGX and 3 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was Samjo Capital, opening a new position worth an estimated $719K. The largest seller was Russell Investments Group, exiting entirely with an estimated $1.13M sold.

  • 22 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q1 2022, down from 26 in Q4 2021.
  • Funds reported $64.9M of Augmedix, Inc. Common Stock stock for Q1 2022, down 6.6% quarter-over-quarter.
  • 3 funds opened new Augmedix, Inc. Common Stock positions in Q1 2022 and 7 closed out, a net change of -4 holders.
  • The largest Augmedix, Inc. Common Stock buyer in Q1 2022 was Samjo Capital, an estimated $719K added.
  • The largest Augmedix, Inc. Common Stock seller in Q1 2022 was Russell Investments Group, an estimated $1.13M sold.

Based on aggregated 13F filings for Q1 2022.